主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文单位:Department of Nephrology People's Hospital Affiliated to Shanxi Medical University Taiyuan 030000 China
关键词:终末期肾病;肾脏替代治疗;血液透析;全国血液净化病例信息登记系统
英文关键词:End-stagerenaldisease;Renalreplacementtherapy;Hemodialysis;ChineseNationalRenalDataSystem
终末期肾病(ESRD)影响人口众多,透析患者的数量也在急剧增加。但不同国家和地区之间使用透析治疗ESRD的方法差异较大,了解透析患者的特征和治疗是评估这部分人群的治疗情况与结果之间关系的第一步。本文根据全国血液净化病例信息登记系统数据,对照国外ESRD的治疗情况和经验,对我国透析患者的医疗状况和特征加以综述,以期提高对ESRD的认识和防范意识,为ESRD患者的治疗决策提供参考。
End-stage renal disease (ESRD) affects a large number of people, and the number of dialysis patients also increases sharply. However, the use of dialysis to treat ESRD varies substantially between different countries and regions. Understanding the characteristics and treatment of dialysis patients is the first step in assessing the relationship between treatment and outcomes in these populations. Based on the Chinese National Renal Data System and the compared with experience and treatment of ESRD abroad, this paper summarizes the medical conditions and characteristics of Chinese dialysis patients, in order to improve the awareness and prevention of ESRD and provide reference for the treatment decision of ESRD patients.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。